SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-013085
Filing Date
2019-07-18
Accepted
2019-07-18 13:31:26
Documents
1
Period of Report
2019-07-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 9280
  Complete submission text file 0001213900-19-013085.txt   10781
Mailing Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019
Business Address 142 W. 57TH STREET, 11TH FLOOR NEW YORK NY 10019 646-844-1164
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3 BLAIR ROAD CAPE TOWN T3 8005
Business Address
Sank Leonard (Reporting) CIK: 0001416089 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35813 | Film No.: 19961040